The smoking–thrombolysis paradox and acute ischemic stroke
- 26 July 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (2) , 293-295
- https://doi.org/10.1212/01.wnl.0000168163.72351.f3
Abstract
Smokers with acute myocardial infarction have better outcomes after thrombolysis than nonsmokers. The authors evaluated the independent effect of smoking on short-term outcome following IV thrombolysis for acute ischemic stroke. After adjusting for covariates, recent smokers who received thrombolysis had a significantly greater drop in 24-hour median stroke severity scores from baseline than nonsmokers who received thrombolysis and lower mortality over 1 year.Keywords
This publication has 10 references indexed in Scilit:
- Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic StrokeStroke, 2005
- Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment TrialStroke, 2004
- Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of StrokeStroke, 2004
- Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysisQJM: An International Journal of Medicine, 1999
- Nicotine Increases Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C–Associated PathwayStroke, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- The Human Costs of Tobacco UseNew England Journal of Medicine, 1994
- Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarctionThe American Journal of Cardiology, 1993
- The cardiovascular pathology of smokingAmerican Heart Journal, 1988
- Catecholamines, cigarette smoking, arrhythmias, and acute myocardial infarctionAmerican Heart Journal, 1974